Gonzaga, Ellamae A.
HRN: 04-04-13 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/20/2025
CEFUROXIME 500MG (TAB)
08/20/2025
08/26/2025
PO
500 Mg
BID
Thickly MSAF
Checking Initial Appropriateness
08/20/2025
METRONIDAZOLE 500MG (TAB)
08/20/2025
08/26/2025
PO
500 Mg
TID
Thickly MSAF
Checking Initial Appropriateness
08/22/2025
CEFUROXIME 500MG (TAB)
08/22/2025
08/28/2025
PO
500mg
BID
THICKLY MSAF
Checking Initial Appropriateness
08/22/2025
METRONIDAZOLE 500MG (TAB)
08/22/2025
08/28/2025
PO
500mg
TID
THICKLY MSAF
Checking Initial Appropriateness